NorthSea Therapeutics
Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
4
Funding Rounds
$136.4m
Money raised
Overview
Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
- Website:
- Business model: B2B
- Headquarters: Amsterdam
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company NorthSea Therapeutics has raised a total of $136.4m in funding over 4 rounds.
Key Insights:
- NorthSea Therapeutics Series B round, January 2020: $40m
- NorthSea Therapeutics January 2020 Series B Funding Round: $40m
- NorthSea Therapeutics Series A round, December 2017: $29.4m
- NorthSea Therapeutics December 2017 Series A Funding Round: $27m
NorthSea Therapeutics Series B round, January 2020
$40m
NorthSea Therapeutics January 2020 Series B Funding Round
$40m
NorthSea Therapeutics Series A round, December 2017
$29.4m
NorthSea Therapeutics December 2017 Series A Funding Round
$27m
Industries
NorthSea Therapeutics is active in the following industries: